Cationic Peptides Modulating Polynucleotide Expression for Sepsis Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for infectious diseases, particularly those involving antibiotic-resistant bacteria, face challenges in effectively managing sepsis and inflammation, as existing therapies can trigger harmful inflammatory responses and may not adequately enhance innate immunity.
Innovation Solution
Development of novel cationic peptides that modulate polynucleotide expression to regulate sepsis and inflammatory responses, identified through screening methods involving contact with sepsis-inducing agents and Toll-like receptors, which can selectively enhance innate immunity without triggering septic reactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat infections, then bacterial infections are controlled, but antibiotic-resistant strains evolve and become untreatable
Solution Approach 1:
The patent identifies and exploits the specific structural features of antibiotic-resistant bacteria (such as altered cell wall composition, efflux pumps, and modified target sites) that confer resistance, and designs cationic peptides that specifically target these same features. By converting the resistance mechanisms into vulnerability points, the peptides achieve effective killing of resistant strains including MRSA and VRE.
Solution Approach 2:
The invention changes the fundamental mechanism of action from traditional antibiotic biochemistry to physical-chemical properties of cationic peptides. These peptides utilize charge interactions, hydrophobic effects, and membrane disruption mechanisms that bypass conventional antibiotic resistance pathways, effectively treating infections that are resistant to standard antibiotic therapies.
2Object-affected harmful factors
If existing therapies are used to manage sepsis and inflammation, then inflammatory responses are suppressed, but harmful inflammatory responses are triggered
Solution Approach 1:
The cationic peptides act as intermediaries that bind to pathogen-associated molecular patterns (PAMPs) and microbial components, preventing their direct interaction with host pattern recognition receptors (PRRs). This intermediary action blocks the activation of inflammatory signaling pathways (such as NF-κB and MAPK) while simultaneously enhancing innate immune effector functions, thereby suppressing harmful inflammation without compromising immune defense.
3Reliability
If innate immunity is enhanced to fight infections, then immune defense is improved, but severe inflammatory responses and sepsis can occur
Solution Approach 1:
The cationic peptides selectively enhance specific components of innate immunity (such as phagocytosis, complement activation, and antimicrobial peptide production) while simultaneously suppressing excessive inflammatory signaling. This partial enhancement approach activates sufficient immune defense to combat infections while preventing the runaway inflammatory response that leads to sepsis and organ failure.
Data Source
AI summary
A method of identifying a polynucleotide or pattern of polynucleotides regulated by one or more sepsis or inflammatory inducing agents and inhibited by a peptide is described. A method of identifying a pattern of polynucleotide expression for inhibition of an inflammatory or septic response. The method includes contacting cells with LPS, LTA, CpG DNA and/or intact microbe or microbial components in the presence or absence of a cationic peptide; detecting a pattern of polynucleotide expression for the cells in the presence and absence of the peptide, wherein the pattern in the presence of the peptide represents inhibition of an inflammatory or septic response. Also included are compounds and agents identified by the methods of the invention. In another aspect, the invention provides methods and compounds for enhancing innate immunity in a subject.